Gemcitabine 38 mg/mL (Gemcitabine INJECTION, SOLUTION) 38 mg/mL

Gemcitabine 38 mg/mL is an injectable solution used for various medical treatments. This single-dose vial is manufactured by Hospira, Inc. and is intended for intravenous administration.

Strength

38 mg/mL

Pack Size

1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0183-01) / 5.26 mL in 1 VIAL, SINGLE-DOSE

Manufacturer / TM Owner

Hospira, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Gemcitabine 38 mg/mL is primarily used in the treatment of certain types of cancer. It works by interfering with the growth of cancer cells, making it a key component in chemotherapy regimens. Patients often wonder, 'What is Gemcitabine used for?' It is commonly prescribed for cancers such as lung, breast, ovarian, and pancreatic cancer. The specific uses of Gemcitabine 38 mg/mL can vary based on individual patient needs and medical history.

Side Effects

Common effects of Gemcitabine 38 mg/mL may include fatigue, nausea, and a decreased appetite. Some patients may experience hair loss or changes in their blood cell counts. These effects can vary in severity and duration, depending on the individual and their treatment plan. It's important to discuss any concerns with a healthcare provider.

Precautions & Warnings

Gemcitabine 38 mg/mL should be handled with care, as it is a potent medication. It is crucial to follow proper storage and disposal guidelines to ensure safety. Patients should inform their healthcare provider about any allergies or medical conditions before starting treatment. Pregnant women should avoid handling this medication due to potential risks.

Avoid Interactions

Gemcitabine 38 mg/mL may interact with other medications, including those that affect the immune system or blood cell production. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also interact with Gemcitabine, so it's best to consult with a healthcare professional before combining treatments.

Frequently Asked Questions

Gemcitabine is used in the treatment of various types of cancer, including lung, breast, ovarian, and pancreatic cancer.

Gemcitabine 38 mg/mL is administered intravenously by a healthcare professional in a clinical setting.

Common side effects may include fatigue, nausea, decreased appetite, and hair loss.

Gemcitabine should be avoided during pregnancy due to potential risks to the fetus.

Gemcitabine should be stored according to the manufacturer's guidelines to maintain its efficacy and safety.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.